Bevacizumab for neovascular age-related macular degeneration (ABC trial)
Evaluation of: Tufail A, Patel PJ, Egan C et al.; ABC Trial Investigators. Bevacizumab for neovascular age related macular degeneration (ABC trial): multicentre randomised double masked study. BMJ 340, c2459 (2010). The ABC trial is the first multicenter, randomized clinical trial that addresses the...
Saved in:
| Main Author: | Ghazi, Nicola G. (author) |
|---|---|
| Format: | article |
| Published: |
2014
|
| Online Access: | http://hdl.handle.net/10725/10852 https://doi.org/10.1586/ecp.10.58 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www.tandfonline.com/doi/full/10.1586/ecp.10.58 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bevacizumab and neovascular age related macular degeneration
by: El Mollayess, Georges
Published: (2011) -
Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?
by: Ghazi, Nicola G.
Published: (2010) -
Intravitreal bevacizumab in the management of neovascular age-related macular degeneration
by: El-Mollayess, Georges M.
Published: (2013) -
Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy
by: Ghazi, Nicola G.
Published: (2001) -
Fixed-interval versus OCT-guided variable dosing of intravitreal bevacizumab in the management of neovascular age-related macular degeneration
by: El-Mollayess, Georges M.
Published: (2012)